Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Oramed Pharmaceuticals Company Profile (NASDAQ:ORMP)

Consensus Ratings for Oramed Pharmaceuticals (NASDAQ:ORMP) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $27.00 (213.59% upside)

Analysts' Ratings History for Oramed Pharmaceuticals (NASDAQ:ORMP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/1/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/30/2014AegisBoost Price TargetBuy$30.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014AegisBoost Price TargetBuy$25.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014MLV & Co Initiated CoverageBuy$27.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)